Annual Accounts Receivable
$4.89 M
+$1.04 M+27.14%
30 April 2024
Summary:
Champions Oncology annual accounts receivable is currently $4.89 million, with the most recent change of +$1.04 million (+27.14%) on 30 April 2024. During the last 3 years, it has risen by +$582.00 thousand (+13.52%). CSBR annual accounts receivable is now -19.07% below its all-time high of $6.04 million, reached on 30 April 2022.CSBR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$4.72 M
-$164.00 K-3.36%
31 July 2024
Summary:
Champions Oncology quarterly accounts receivable is currently $4.72 million, with the most recent change of -$164.00 thousand (-3.36%) on 31 July 2024. Over the past year, it has dropped by -$58.00 thousand (-1.21%). CSBR quarterly accounts receivable is now -21.78% below its all-time high of $6.04 million, reached on 30 April 2022.CSBR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.1% | -1.2% |
| 3 y3 years | +13.5% | +1.5% |
| 5 y5 years | +146.5% | +105.5% |
CSBR Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.1% | +27.1% | -21.8% | +22.9% |
| 5 y | 5 years | -19.1% | +146.5% | -21.8% | +105.5% |
| alltime | all time | -19.1% | -21.8% |
Champions Oncology Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $4.72 M(-3.4%) |
| Apr 2024 | $4.89 M(+27.1%) | $4.89 M(+5.0%) |
| Jan 2024 | - | $4.65 M(-2.7%) |
| Oct 2023 | - | $4.78 M(-16.2%) |
| July 2023 | - | $5.71 M(+48.5%) |
| Apr 2023 | $3.84 M(-36.3%) | $3.84 M(-23.9%) |
| Jan 2023 | - | $5.05 M(-6.3%) |
| Oct 2022 | - | $5.39 M(-4.0%) |
| July 2022 | - | $5.62 M(-6.9%) |
| Apr 2022 | $6.04 M(+40.3%) | $6.04 M(+24.3%) |
| Jan 2022 | - | $4.86 M(+4.4%) |
| Oct 2021 | - | $4.65 M(+4.2%) |
| July 2021 | - | $4.46 M(+3.7%) |
| Apr 2021 | $4.30 M(+62.1%) | $4.30 M(+29.1%) |
| Jan 2021 | - | $3.33 M(+2.6%) |
| Oct 2020 | - | $3.25 M(+23.4%) |
| July 2020 | - | $2.63 M(-0.8%) |
| Apr 2020 | $2.65 M(+34.0%) | $2.65 M(-13.6%) |
| Jan 2020 | - | $3.07 M(+33.7%) |
| Oct 2019 | - | $2.30 M(+16.5%) |
| July 2019 | - | $1.97 M(-0.5%) |
| Apr 2019 | $1.98 M(+7.9%) | $1.98 M(-16.3%) |
| Jan 2019 | - | $2.37 M(-23.9%) |
| Oct 2018 | - | $3.11 M(+169.9%) |
| July 2018 | - | $1.15 M(-37.2%) |
| Apr 2018 | $1.84 M(-19.2%) | $1.84 M(-37.6%) |
| Jan 2018 | - | $2.94 M(+14.1%) |
| Oct 2017 | - | $2.58 M(-3.3%) |
| July 2017 | - | $2.67 M(+17.3%) |
| Apr 2017 | $2.27 M(+212.8%) | $2.27 M(+12.2%) |
| Jan 2017 | - | $2.03 M(+7.1%) |
| Oct 2016 | - | $1.89 M(+16.2%) |
| July 2016 | - | $1.63 M(+123.9%) |
| Apr 2016 | $727.00 K(+70.7%) | $727.00 K(-65.5%) |
| Jan 2016 | - | $2.10 M(+11.3%) |
| Oct 2015 | - | $1.89 M(+29.7%) |
| July 2015 | - | $1.46 M(+242.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2015 | $426.00 K(-3.8%) | $426.00 K(-61.0%) |
| Jan 2015 | - | $1.09 M(-2.1%) |
| Oct 2014 | - | $1.11 M(+20.5%) |
| July 2014 | - | $925.00 K(+108.8%) |
| Apr 2014 | $443.00 K(+38.9%) | $443.00 K(-85.8%) |
| Jan 2014 | - | $3.12 M(+113.6%) |
| Oct 2013 | - | $1.46 M(-18.0%) |
| July 2013 | - | $1.78 M(+459.2%) |
| Apr 2013 | $319.00 K(-35.4%) | $319.00 K(-50.3%) |
| Jan 2013 | - | $642.00 K(+2.4%) |
| Oct 2012 | - | $627.00 K(-1.9%) |
| July 2012 | - | $639.00 K(+29.4%) |
| Apr 2012 | $494.00 K(-15.6%) | $494.00 K(-0.6%) |
| Jan 2012 | - | $497.00 K(-40.3%) |
| Oct 2011 | - | $832.00 K(-32.7%) |
| July 2011 | - | $1.24 M(+111.3%) |
| Apr 2011 | $585.00 K(+557.3%) | $585.00 K(+59.8%) |
| Jan 2011 | - | $366.00 K(+9.3%) |
| Oct 2010 | - | $335.00 K(+915.2%) |
| July 2010 | - | $33.00 K(-62.9%) |
| Apr 2010 | $89.00 K(>+9900.0%) | $89.00 K(-78.5%) |
| Jan 2010 | - | $414.00 K(+475.0%) |
| Oct 2009 | - | $72.00 K(>+9900.0%) |
| Apr 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Oct 2008 | - | $77.10 K(+1143.5%) |
| July 2008 | - | $6200.00(+1140.0%) |
| Jan 2005 | - | $500.00(-95.5%) |
| Oct 2004 | - | $11.00 K(-51.5%) |
| Apr 2004 | $22.70 K(>+9900.0%) | $22.70 K(>+9900.0%) |
| Jan 2003 | - | $0.00(-100.0%) |
| Oct 2002 | - | $5200.00(+5100.0%) |
| Apr 2002 | $100.00(-92.3%) | $100.00(-66.7%) |
| Jan 2002 | - | $300.00(0.0%) |
| Oct 2001 | - | $300.00(-76.9%) |
| Apr 2001 | $1300.00 | $1300.00(-62.9%) |
| Jan 2001 | - | $3500.00(-41.7%) |
| Oct 2000 | - | $6000.00(-96.8%) |
| July 2000 | - | $185.60 K |
FAQ
- What is Champions Oncology annual accounts receivable?
- What is the all time high annual accounts receivable for Champions Oncology?
- What is Champions Oncology annual accounts receivable year-on-year change?
- What is Champions Oncology quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Champions Oncology?
- What is Champions Oncology quarterly accounts receivable year-on-year change?
What is Champions Oncology annual accounts receivable?
The current annual accounts receivable of CSBR is $4.89 M
What is the all time high annual accounts receivable for Champions Oncology?
Champions Oncology all-time high annual accounts receivable is $6.04 M
What is Champions Oncology annual accounts receivable year-on-year change?
Over the past year, CSBR annual accounts receivable has changed by +$1.04 M (+27.14%)
What is Champions Oncology quarterly accounts receivable?
The current quarterly accounts receivable of CSBR is $4.72 M
What is the all time high quarterly accounts receivable for Champions Oncology?
Champions Oncology all-time high quarterly accounts receivable is $6.04 M
What is Champions Oncology quarterly accounts receivable year-on-year change?
Over the past year, CSBR quarterly accounts receivable has changed by -$58.00 K (-1.21%)